{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:58:30Z","timestamp":1792155510388,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.compbiolchem.2025.108371","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T14:57:29Z","timestamp":1739113049000},"page":"108371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Design of BBB permeable BACE-1 inhibitor as potential drug candidate for Alzheimer disease: 2D-QSAR, molecular docking, ADMET, molecular dynamics, MMGBSA"],"prefix":"10.1016","volume":"116","author":[{"given":"Navneet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogita","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.compbiolchem.2025.108371_bib1","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/jm201181f","article-title":"Design, synthesis, and qualitative structure\u2013activity evaluations of novel \u03b2-Secretase inhibitors as potential Alzheimer\u2019s drug leads","volume":"54","author":"Al-Tel","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ejmech.2017.06.040","article-title":"Discovery of imidazopyridines containing isoindoline-1, 3-dione framework as a new class of BACE1 inhibitors: design, synthesis and SAR analysis","volume":"138","author":"Azimi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108371_bib3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1039\/C9MD00337A","article-title":"Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands","volume":"10","author":"Blaikie","year":"2019","journal-title":"Med. Chem. Comm."},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108371_bib4","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.bmcl.2009.03.149","article-title":"Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics","volume":"19","author":"Charrier","year":"2009","journal-title":"Bioor. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108371_bib5","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1016\/j.bmcl.2009.03.150","article-title":"Second generation of BACE-1 inhibitors part 2: optimisation of the non-prime side substituent","volume":"19","author":"Charrier","year":"2009","journal-title":"Bioor. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108371_bib6","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1016\/j.bmcl.2009.03.165","article-title":"Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics","volume":"19","author":"Charrier","year":"2009","journal-title":"Bioor. Med. Chem. Lett."},{"issue":"s1","key":"10.1016\/j.compbiolchem.2025.108371_bib7","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.3233\/JAD-240146","article-title":"BACE1 inhibitors for Alzheimer\u2019s disease: current challenges and Future perspectives","volume":"101","author":"Coimbra","year":"2024","journal-title":"J. Alzheimer\u2019S. Dises."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib8","article-title":"Rational design of novel diaryl ether-linked benzimidazole derivatives as potent and selective BACE1 inhibitors","volume":"698","author":"De","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108371_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bmcl.2015.11.033","article-title":"Synthesis of (3S, 4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities","volume":"26","author":"De Tran","year":"2016","journal-title":"Bioorg. & Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib10","doi-asserted-by":"crossref","unstructured":"Dearden J.C. The history and development of quantitative structure-activity relationships (QSARs). In Oncology: breakthrough in Res. And Practice 2017:67-117. IGI Global. https:\/\/doi.org\/10.4018\/IJQSPR.2016010101.","DOI":"10.4018\/978-1-5225-0549-5.ch003"},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108371_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/molecules28020776","article-title":"Evaluation of free online ADMET tools for academic or small biotech environments","volume":"28","author":"Dulsat","year":"2023","journal-title":"Mol"},{"key":"10.1016\/j.compbiolchem.2025.108371_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113492","article-title":"Dual-target compounds for Alzheimer's disease: natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)","volume":"221","author":"Ferreira","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","author":"Fu","year":"2024","journal-title":"Nucleic Acid. Res"},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108371_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/1062936X.2024.2332203","article-title":"In silico insights into design of novel VEGFR-2 inhibitors: SMILES-based QSAR modelling, and docking studies on substituted benzo-fused heteronuclear derivatives","volume":"35","author":"Gupta","year":"2024","journal-title":"SAR QSAR Env. Res."},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108371_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jccs.201900200","article-title":"Exploring beta amyloid cleavage enzyme-1 inhibition and neuroprotective role of benzimidazole analogues as anti-Alzheimer agents","volume":"67","author":"Gurjar","year":"2020","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2017.07.014","article-title":"Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer\u2019s disease","volume":"74","author":"Haghighijoo","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bioorg.2018.01.017","article-title":"Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease","volume":"77","author":"Iraji","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.compbiolchem.2025.108371_bib18","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.3390\/molecules17078312","article-title":"From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer\u2019s disease","volume":"17","author":"Jiaranaikulwanitch","year":"2012","journal-title":"Mol"},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108371_bib19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00204-022-03252-y","article-title":"K. Prediction reliability of QSAR models: an overview of various validation tools","volume":"96","author":"Kar","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"14","key":"10.1016\/j.compbiolchem.2025.108371_bib20","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1016\/j.bmcl.2012.05.072","article-title":"Synthesis and structure\u2013activity relationship studies of 1, 3-disubstituted 2-propanols as BACE-1 inhibitors","volume":"22","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.compbiolchem.2025.108371_bib21","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1016\/j.bmcl.2010.06.089","article-title":"Fragment-based discovery and optimization of BACE1 inhibitors","volume":"20","author":"Madden","year":"2010","journal-title":"Bioor. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108371_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bmcl.2010.10.079","article-title":"Synthesis and SAR of indole-and 7-azaindole-1, 3-dicarboxamide hydroxyethylamine inhibitors of BACE-1","volume":"21","author":"Marcin","year":"2011","journal-title":"Bioor. Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib23","doi-asserted-by":"crossref","unstructured":"Mathieu, M., Dupuy, A.S., 2024. Human Bace (beta secretase) in complex with Cyclohexane carboxylic acid (2-(2-am ino-6-phenoxy-4H-quinazolin-3-yl)-2 -cyclohexyl-ethyl) amide. 2024,20. https:\/\/doi.org\/10.2210\/pdb2wjo\/pdb.","DOI":"10.2210\/pdb2wjo\/pdb"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108371_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors: current status and future directions in treating Alzheimer's disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib25","first-page":"1","article-title":"Integrated computational approaches for identification of potent pyrazole-based glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) inhibitors: 3D-QSAR, virtual screening, docking, MM\/GBSA, EC, MD simulation studies","author":"Niharika","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104568","article-title":"Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity","volume":"107","author":"Nuthakki","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Chemin.-."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108371_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chemolab.2011.08.007","article-title":"Comparative QSARs for antimalarial endochins: Importance of De descriptor-thinning and noise reduction prior to feature selection. Chemometr","volume":"109","author":"Ojha","year":"2011","journal-title":"Chemom. Intell. Labor. Syst."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-0716-3311-3_3","article-title":"Recent Advances in Computational Modeling of BACE1 inhibitors as anti-alzheimer agents","author":"Papavasileiou","year":"2023","journal-title":"Comput. Modell. Drugs Alzheimer\u2019S. Dis."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108371_bib30","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1021\/acsomega.9b00198","article-title":"Arylbenzofurans from the root bark of Morus alba as triple inhibitors of cholinesterase, \u03b2-site amyloid precursor protein cleaving enzyme 1, and glycogen synthase kinase-3\u03b2: Relevance to Alzheimer\u2019s disease","volume":"4","author":"Paudel","year":"2019","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108371_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14737175.2023.2284305","article-title":"\"Advances in amyloid-targeting monoclonal antibodies for Alzheimer\u2019s disease: clinical and public health issues","volume":"23","author":"Salemme","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.08.060","article-title":"Moracin derivatives from Morus Radix as dual BACE1 and cholinesterase inhibitors with antioxidant and anti-glycation capacities","volume":"210","author":"Seong","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108371_bib33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1042\/BST0350574","article-title":"The proteins BACE1 and BACE2 and \u03b2-secretase activity in normal and Alzheimer's disease brain","volume":"35","author":"Stockley","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.compbiolchem.2025.108371_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ejmech.2016.11.021","article-title":"Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease","volume":"125","author":"Tarazi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108371_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22214","article-title":"Synthesis of new N-(5, 6-methylenedioxybenzothiazole-2-yl)-2-[(substituted) thio\/piperazine] acetamide\/propanamide derivatives and evaluation of their AChE, BChE, and BACE-1 inhibitory activities","volume":"85","author":"Tutu\u015f","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108371_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1389450122666210809100050","article-title":"Alzheimer's disease and \u03b2-secretase inhibition: an update with a focus on computer-aided inhibitor design","volume":"23","author":"Ugbaja","year":"2022","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.compbiolchem.2025.108371_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejmech.2016.03.075","article-title":"The Monte Carlo technique as a tool to predict LOAEL","volume":"116","author":"Veselinovi\u0107","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.compbiolchem.2025.108371_bib38","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1021\/jm300119p","article-title":"Design and preparation of a potent series of hydroxyethylamine containing \u03b2-secretase inhibitors that demonstrate robust reduction of central \u03b2-amyloid","volume":"55","author":"Weiss","year":"2012","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.compbiolchem.2025.108371_bib39","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1016\/j.bmcl.2010.08.111","article-title":"Molecular docking and structure\u2013activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors","volume":"20","author":"Xu","year":"2010","journal-title":"Bioor. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.compbiolchem.2025.108371_bib40","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.3390\/molecules18055706","article-title":"Virtual screening and structure-based discovery of indole acylguanidines as potent \u03b2-secretase (BACE1) inhibitors","volume":"18","author":"Zou","year":"2013","journal-title":"Mol"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:05:02Z","timestamp":1741295102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S1476927125000313"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108371","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of BBB permeable BACE-1 inhibitor as potential drug candidate for Alzheimer disease: 2D-QSAR, molecular docking, ADMET, molecular dynamics, MMGBSA","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108371"}}